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Abstract: Current therapeutic for the treatment of anxiety is associated with a wild 
variety of side effects. The traditional use of plant extract to health care can indicate 
an important source of new pharmaceuticals. Bowdichia virgilioides Kunth, Fabaceae, 
is a plant commonly employed in the Brazilian folk medicine to treat infl ammatory 
conditions. Nevertheless, despite its popular use there are no studies related to its 
possible neuropharmacological effect. Here, we investigated the possible anxiolytic 
effect of the extract of B. virgilioides after acute and sub-chronic treatment in mice. 
The aqueous extract from the stem barks of B. virgilioides (20, 200 or 400 mg/kg) 
was orally administered, and its anxiolytic effect was evaluated in the elevated plus 
maze, open-fi eld and rota-rod tests. Diazepam was employed as standard drug. The 
aqueous extract treatment was effective in inducing anxiolytic effects with single acute 
treatment, a phenomenon that remained after chronic treatment. However, no changes in 
spontaneous locomotor activity or myorelaxant effect after aqueous extract treatment. 
The extract was either safe with no deaths in mice treated orally with 1000 mg/kg. 
These fi ndings suggest that the aqueous extract from the stem barks of Bowdichia 
virgilioides has an acute and sub-chronic anxiolytic-like effect without compromising 
motor activity, demonstrating an advantage regarding to antidepressant drugs.
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Introduction
 Anxiety is considered a common emotional 
phenomenon in the human population, occurring in 
response to physiological and/or environmental factors. 
However, it can be a cause of disturbance in daily life and 
can express a pathological state (Clement & Chapouthier, 
1998). Pharmacological treatment for anxiety disorder 
consists of the use of benzodiazepines and antidepressant 
drugs; however, although these treatments showing clinical 
effi cacy, they have several problems. Benzodiazepines can 
lead to disturbing effects, such as amnesia, dependence 
liability, and sedation. The antidepressants can lead to sexual 
dysfunction, insomnia, and gastrointestinal disturbances 
(Mitte et al., 2005; Zarrindast et al., 2008). Thus, there is a 
need for the development of new anxiolytic drugs that lack 
these effects. In this context, medicinal plants continue to 
have anxiolytic potential (Carlini, 2003).
 Several traditionally used plants exhibit 
pharmacological properties with great potential for 
therapeutic applications in the treatment of central nervous 
system disorders, such as anxiety disorders (Faustino et 
al., 2010). In folk medicine, some species belonging 
to the family Fabaceae, such as Erythrina falcata and 
Melilotus offi cinalis, are known to possess anxiolytic 
action (Almeida, 2010). Moreover, Ribeiro et al. (2006) 
in recent studies revealed anxiolytic-like effects of another 
member of Fabaceae family, Erythrina velutina, in animal 
models of anxiety. This study showed that acute and 
chronic administration of the hydroalcoholic extract of 
stem bark from E. velutina impaired inhibitory avoidance 
in the elevated T-maze test, which suggests an anxiolytic-
like effect (Ribeiro et al., 2006).
 Bowdichia virgilioides Kunth, Fabaceae, is 
popularly known as “sucupira-preta” in northeastern Brazil 
(Almeida et al., 1998). In folk medicine, its seeds are used 
in the treatment of rheumatism, arthritis, and skin diseases; 
its bark is employed as an antidiabetic agent and is utilized 
for healing in the topical treatment of infl ammations 
(Albuquerque et al., 2007). There are few scientifi c studies 
dealing with the biological activity of this species, but 
some reports have demonstrated its antimalarial property 
(Deharo et al., 2001) as well as an important antinociceptive 
action in models of peripheral analgesia (Silva et al, 2010) 
and anti-infl ammatory activity (Thomazzi et al., 2010). 
Previous investigations have described the presence of 
several components in this species, such as essential oil 
(Arriaga et al., 1998), alkaloids (Torrenegra et al., 1989), 
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flavonoids (Velozo et al., 1999), triterpenoids (Melo et 
al., 2001), and resins (Machado, 1936). Although these 
secondary metabolites has been reported as anxiolytic-like 
in previous studies, we found no reference on activity of 
aqueous extract from B. virgilioides on the central nervous 
system relating to anxiety as well as information on its 
acute toxicity. Since all these the secondary metabolites 
are possessed of an anxiolytic-like effect, it is reasonable 
to predict that extract crude that gathers them all may exert 
therapeutic effects on treat anxiety.
 Considering that current therapeutics for the 
treatment of anxiety, such as benzodiazepinics, have well-
known benefits for treating anxiety, and its use is associated 
with different side effects, including tolerance that limits 
their use, the replacement with herbal remedies could 
provide real cure over long time treatment. Therefore, the 
objective of the present work was to evaluate the anxiolytic 
effect of the aqueous extract from Bowdichia virgilioides 
in mice.
Materials and Methods
Plant material 
 The stem barks of Bowdichia virgilioides Kunth, 
Fabaceae, were collected in March 2006 at the Arboretum 
of the Federal University of Alagoas, Brazil. The plant 
was taxonomically identified by the expert in Botanics 
Rosangela P. Lyra Lemos of the Alagoas Environment 
Institute (Instituto de Meio Ambiente de Alagoas), and a 
voucher specimen was deposited in the IMA herbarium 
situated in Maceió, Alagoas, Brazil, under number 
MAC29914.
Preparation of the plant extract
 The stem barks of B. virgilioides were dried at 
ambient temperature and triturated. The aqueous extract 
of B. virgilioides (AEBv) was prepared by infusing 50 μg 
of powdered plant material for 20 min using 300 μmL of 
boiling water. After filtration, the extract was concentrated 
until total solvent evaporation was achieved by means of 
a rotary evaporator, and lyophilization was accomplished. 
The yield of the infusion was 17.2%. The extract was 
reconstituted in 0.9% NaCl solution (vehicle) before the 
treatments at the required doses.
Animals
 Male Swiss mice (20-25g) were obtained from 
the Central Animal Housing facilities of the Federal 
University of Alagoas. The animals were maintained 
in cages under standard conditions of controlled light 
(light/dark cycle of 12 h) at 22±2 oC and access to 
food and water ad libitum. All animal experimentation 
was carried out in accordance with institutional ethics 
guidelines of the Federal University of Alagoas (license 
number: 010095/2009-67).
Drugs and treatments
 Animals were randomly assigned to one of two 
administration regimes: Acute or sub-chronic. Within each 
treatment, animals received by gavage (p.o.) a volume of 
200 μL, and were further divided into five treatment groups 
(n=9/treatment): B. virgilioides extract (AEBv, 20, 200 or 
400 mg/kg), diazepam (5 mg/kg, i.p.; Roche, Brazil), and 
vehicle (NaCl, 0.9 %).
 For the acute treatment groups, animals received 
a single dose with AEBv (20, 200 or 400 mg/kg), diazepam 
or vehicle. One hour after the treatment, each animal was 
conducted to behavioral tests. Animals in the sub-chronic 
groups, received daily treatments for seven days and were 
tested 24 h following the final dose. The B. virgilioides 
extract dose and the protocol treatment were based on 
preliminary studies (Thomazzi et al., 2010; Silva et al., 
2010; Anuradha et al., 2008; Harsha & Anilakumar, 2013) 
with different extract doses administered to mice with 
some modifications. 
Behavioral tests
 To assess the effect of AEBv on the behavior of 
the studied animals, two types of behavioral models were 
investigated: elevated plus maze test and open-field test. 
The animals were used only once for the behavioral test, 
and the apparatus was cleaned with 10% alcohol between 
each experiment.
Elevated plus maze test
 Behavior in the elevated plus maze (EPM) is used 
to assess exploration, anxiety, and motor behavior. The 
possible anxiolytic effects of the aqueous extract of AEBv 
were assessed, basically using the same method described 
by Komada et al. (2008). The EPM consists of four arms, 
40 cm long and 20 cm wide, arranged in such a way that 
the two arms of each type were opposite to each other. The 
maze was elevated 50 cm above the floor. Two arms were 
enclosed by walls 30  cm high and the other two arms were 
exposed.
 Mice received AEBv (20, 200 or 400 mg/kg, 
p.o.), or vehicle once per day for seven days to sub-
chronic treatment, while that to acute treatment 1h after 
oral administration (AEBv or vehicle) was conducted the 
behavior test. The positive control diazepam (5 mg/kg, i.p.) 
was given once 30  min before the test. After treatment, 
each animal was placed at the center of the maze facing 
one of the enclosed arms. During a 5 min test period, the 
number of open and enclosed arms entries, as well as the 
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time spent in open arms was recorded. Entry into an arm 
was defined as the point when the animal places all four 
paws into the arm.
Open-field test
 The locomotor and exploratory behavior was 
assessed in an OFT. The open-field was made of glass 
cube and surrounded by walls 30 cm in height. The floor 
of the open-field, 10 cm in length and 10 cm in width, was 
divided into nine squares. Animals were evaluated 1 h after 
a single oral dose of vehicle, AEBv (20, 200 or 400 mg/kg) 
or diazepam. Each animal was placed individually at the 
center of the apparatus and observed for 5 min to record 
the locomotor (expressed by squares entered and crossing 
with the four paws) and exploratory activities (expressed 
by the number of rearing on the hind limbs).
Rota rod test
 To discard possible nonspecific effects of the 
AEBv on motor coordination or on muscle relaxation the 
mice were tested on the rota-rod. The animals were trained 
on the apparatus for two days before the experiment. On the 
day of the experiment, mice were treated with AEBv (200 
or 400 mg/kg, p.o.) or diazepam (5 mg/kg, i.p.) and tested 
in the rota-rod from 60 min after their administration. After 
treatment, the motor performance time (s) was recorded 
with a stopwatch for up to 240 s (de Oliveira et al., 2012).
Acute toxicity test
 The acute toxicity test for AEBv was carried 
out to evaluate any possible toxicity. Mice (n=6) of 
either sex were tested by administering at only dose 
Figure 1. Effects of the aqueous extract from stem barks of Bowdichia virgilioides (AEBv) in the absolute time spent in the open arms 
(A and D), number of entries in the open arms (B and E), and number entries into closed arms (C and F) during 5 min of exposure to 
the elevated plus maze. Animals were acutely (A, B and C) or sub-chronically treated (D, E and F) with saline 0.9% NaCl (control 
group), AEBv (20, 200, and 400 mg/kg), or diazepam (DZP: 5 mg/kg) prior to the test. Data are presented as mean±SEM (n=9 per 
group). *p<0.05, **p<0.005, ***p<0.0001 compared to the control group.
                       acute administration                                          sub-chronic administration
(A)
(B)
(C)
(D)
(E)
(F)
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1000 mg/kg (p.o.) of AEBv, while the control group 
received distilled water (10 mL/kg). All the groups 
were observed for any gross effect for the first 4 h and 
then mortality was observed after 24 h (Bruce, 1985).
Statistical analysis 
 Analysis and graphs construction were 
performed using the software GraphPad Prism version 
5.00 (GraphPad Prism Software, Inc.). The results were 
analyzed by one-way ANOVA followed by Tukey’s test, 
and data are presented as mean±SEM. Values of p≤0.05 
were considered significant.
Results
 As shown in Figure 1, acute treatment with AEBv 
at doses of 20, 200 or 400 mg/kg, p.o., induced a sedative 
effect in mice when assessed by the elevated pluz maze 
test (EPM). The results (Figure 1A and B) showed that 
the time the animals remained in the open arms (p<0.05) 
and the number of entrances into the open arms (p<0.001) 
were significantly increased than compared with the 
controls. Diazepam (5 mg/kg, i.p.), used as a positive 
control, produced a statistically significant increase in both 
parameters. The other behavioral parameter evaluated 
in the EPM, such as entries on enclosed arms, was not 
significantly altered by any dose of AEBv than compared 
to control group (Figure 1C). These effects were similar to 
those obtained for diazepam (Figure 1C).
 The sub-chronic treatment with AEBv showed a 
significant increase in the time that the animals remained 
in the open arms and the number of entrances into the open 
arms (Figure 1D and E). In addition, as well as in acute 
treatment, the sub-chronical protocol did not affect the 
number of entries on enclosed arms (Figure 1C).
 In the open-field test, both treatments with AEBv 
(20, 200 or 400 mg/kg, p.o.) acute (Figure 2A and B) or 
sub-chronic (Figure 2C and D) did not was able to alter 
the number of crossings and rearings, as compared to 
control group. Moreover, mice treated with one only dose 
of diazepam showed alterations in the locomotor activity 
when compared with the control group (Figure 2A). In 
addition, no difference was observed in locomotor activity 
between groups after acute and sub-chronic treatment.
 The rota-rod test was carried out to measure 
locomotor impairment in mice treated acutely or repeatedly 
with AEBv. In this study, AEBv-treated mice did not 
show any significant motor performance alterations with 
the dose of 200 or 400 mg/kg p.o. (223.63±11.58 s and 
209.88±11.90, respectively) as compared to saline-treated 
animals (187.25±34.54 s) in the rota-rod test. As expected, 
diazepam (positive control, 5 mg/kg, i.p.) reduced the 
motor performance time of mice after 30 min of treatment 
Figure 2. Effects of the aqueous extract from stem barks of Bowdichia virgilioides (AEBv) on the total number of squares entered 
(A and C) and number of rearings (B and D) during 5 min of exposure to the open-field test. Animals were acutely (A, B) or sub-
chronically treated (C, D) with saline 0.9% NaCl (control group), AEBv (20, 200, and 400 mg/kg), or diazepam (DZP: 5 mg/kg) prior 
to the test. Data are shown as mean±SEM (n=9 per group). *p<0.01 compared to the control group.
                     acute administration                                       sub-chronic administration
(A)
(B) (D)
(C)
Anxiolytic-like effect of the extract from Bowdichia virgilioides in mice
Larissa Fernanda de A. Vieira et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 23(4): Jul./Aug. 2013684
(29.69±18.21 s). Furthermore, no gross behavior change or 
mortality was observed at the tested doses and, therefore, 
the extract is considered to be safe up to the dose of 1000 
mg/kg.
Discussion
 Despite its use in traditional Brazilian medicine 
to treat pain, inflammatory diseases, or even act in 
wound healing, Bowdichia virgilioides Kunth, Fabaceae, 
has not yet been evaluated for its activity on the CNS. 
Furthermore, to our knowledge there are no reports 
about sedative or anxiolytic effects of B. virgilioides. 
Thus, the aim of the present study was evaluate, for 
the first time, the anxiolytic properties produced by 
aqueous stem bark extract from B. virgilioides (AEBv) 
in behavioral models.
 The present study showed that acute or sub-
chronic administration of AEBv, in the elevated plus-maze 
test, induced an increase in the exploration and the time 
spent into the open arms (i.e., anxiolytic-like action) in 
a non-dose-related way. The number of entries into the 
enclosed arms did not changed by the oral treatment with 
the AEBv in comparison to the control values. The elevated 
plus-maze is a well-accepted, experimental animal model 
typically used to test the effectiveness of anxiolytics drugs 
(Pellow et al., 1985; Hogg, 1996). Drugs that increase the 
open arms exploration are considered anxiolytics and the 
reverse holds true for anxiogenic compounds (Handley 
& McBlane, 1993). As expected, diazepam increased 
the activity in the open arms of the elevated plus-maze 
apparatus, confirming its anxiolytic actions. 
 It is widely accepted that benzodiazepinic after 
a continuous administration promotes anxiolytic effect. 
However, this drug also produces effects as anticonvulsants, 
and also produces sedation and myorelaxant effects after 
chronicle usage (Melo et al., 2006). In this study, we 
observed that the anxiolytic effects of EABv were achieved 
after acute treatment, not being necessary the use of the 
extract for a prolonged period. Thus, the extract can exert 
an acute effect which can be very interesting since first 
choice drugs as antidepressant induce its therapeutic effect 
only after the third week of continuous use.
 Data in the literature demonstrated that drugs 
that alter general motor activity may give false-positive/
negative results in the plus maze test (Treit & Fundytus, 
1988). Therefore, in order to verify the relation between 
the anxiolytic effect of AEBv and a locomotor activity 
alteration, it was decided to use, in our protocol, the 
open field test, a classic animal model used to assess the 
autonomic effects of drugs and the general activity of 
animals (Prut & Belzung, 2003). In this test, the groups 
that received treatment acute or sub-chronical with AEBv 
at doses which produced an anxiolytic-like effect did not 
alter locomotor activity phenomenon that was different of 
animals diazepam-treated, suggesting that this plant may 
not produce undesirable sedative side effects. 
 A deficit in motor coordination would very likely 
affect performance in the plus maze and open field tests. 
In this way, we aimed to investigate the effects of AEBv in 
the rota rod test, a classic animal model used to evaluate 
peripheral neuromuscular blockage. The findings showed 
that AEBv, in contrast to diazepam, had no significant 
effect on the motor coordination of animals on the rota rod 
test, suggesting that the anxiolytic-like effect might not be 
exerted through peripheral neuromuscular blockage, but 
rather, elicited centrally.
 Presently, there are no reported active 
constituents from the stem barks aqueous extract of 
this plant; however, a large number of compounds, 
including alkaloids (Barbosa-Filho et al. 2004), lupeol, 
sitosterol and stigmasterol (Melo et al. 2001), have 
been reported in the literature. The anxiolytic effect of 
alkaloids (Martínez-Vázquez et al., 2012), flavonoids 
(Li et al., 2011) and saponins (Wei et al., 2007) has been 
previously reported and, therefore, we suggest that these 
anxiolytic effects may be due to the above constitutes. 
Moreover, cannot be discarded a possible mechanism 
of action anxiolytic of B. virgilioides mediated by a 
synergistic action of these phytochemicals.
 In summary, even that the anxiolytic-like effect 
observed after sub-chronic treatment has exerted a more 
significant effect, we cannot discard the anxiolytic-like 
effect observed after acute treatment with the extract. 
This result shows an advantage over the commonly used 
drugs in the treatment of anxiety disorders.  Thus, this is 
the first time that an anxiolytic-like effect that does not 
affect the locomotor activity is suggested for AEBv, at 
the doses tested herein. Further studies are underway, in 
order to elucidate the possible mechanisms involved in the 
anxiolytic activity of this extract.
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